Lotus Pharmaceutical Co Ltd (1795) — Cash Flow Reinvestment Rate
Lotus Pharmaceutical Co Ltd (1795) has a Cash Flow Reinvestment Rate of 1.19x as of December 2025, reinvesting NT$1.60 Billion (capex NT$1.60 Billion ) from operating cash flow of NT$1.35 Billion. See 1795 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lotus Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Lotus Pharmaceutical Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see Lotus Pharmaceutical Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Lotus Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Lotus Pharmaceutical Co Ltd. See financial flexibility index of Lotus Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$4.35 Billion | NT$7.48 Billion | NT$4.35 Billion | ▲ +144.4% |
| 2024 | 0.24x | NT$1.47 Billion | NT$6.15 Billion | NT$1.47 Billion | ▼ -94.1% |
| 2023 | 4.04x | NT$6.52 Billion | NT$1.61 Billion | NT$3.28 Billion | ▲ +596.0% |
| 2022 | 0.58x | NT$2.16 Billion | NT$3.72 Billion | NT$577.16 Million | ▼ -97.8% |
| 2021 | 26.73x | NT$3.20 Billion | NT$119.66 Million | NT$1.62 Billion | ▲ +2491.9% |
| 2020 | 1.03x | NT$2.01 Billion | NT$1.95 Billion | NT$2.00 Billion | ▼ -81.8% |
| 2019 | 5.68x | NT$1.72 Billion | NT$302.81 Million | NT$1.10 Billion | ▲ +345.6% |
| 2018 | 1.27x | NT$1.02 Billion | NT$796.98 Million | NT$399.07 Million | ▼ -19.7% |
| 2017 | 1.59x | NT$940.19 Million | NT$592.29 Million | NT$914.84 Million | ▲ +58.1% |
| 2016 | 1.00x | NT$1.24 Billion | NT$1.23 Billion | NT$660.48 Million | ▲ +107.7% |
| 2015 | 0.48x | NT$520.71 Million | NT$1.08 Billion | NT$520.71 Million | ▼ -80.6% |
| 2010 | 2.49x | NT$147.57 Million | NT$59.19 Million | NT$147.57 Million | ▲ +786.5% |
| 2009 | 0.28x | NT$25.17 Million | NT$89.50 Million | NT$25.17 Million | — |